Cargando…
Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy
During the current formidable COVID-19 pandemic, it is appealing to address ideas that may invoke therapeutic interventions. Clotting disorders are well recognized in patients infected with severe acute respiratory syndrome (SARS) caused by a novel coronavirus (SARS-CoV-2), which lead to severe comp...
Autores principales: | Kinaneh, Safa, Khamaysi, Iyad, Karram, Tony, Hamoud, Shadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255537/ https://www.ncbi.nlm.nih.gov/pubmed/34132790 http://dx.doi.org/10.1042/BSR20210290 |
Ejemplares similares
-
SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection
por: Imig, John D.
Publicado: (2022) -
Heparanase Inhibition Prevents Liver Steatosis in E(0) Mice
por: Kinaneh, Safa, et al.
Publicado: (2022) -
Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs
por: Pelisek, Jaroslav, et al.
Publicado: (2022) -
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease
por: Avolio, Elisa, et al.
Publicado: (2021) -
Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure
por: Cohen-Segev, Ravit, et al.
Publicado: (2023)